Just Earth News | @justearthnews | 02 Apr 2021, 05:49 am Print
Astrazeneca Image: Wikimedia Commons
Moscow/Sputnik: A man was hospitalized in Australia with a rare clotting disorder on Friday, just days after receiving the AstraZeneca/Oxford COVID-19 vaccine, national media reported.
According to ABC News, 44-year-old man, who was inoculated on or around March 22, is now being treated in a Melbourne hospital.
"He had low platelets, but he had clots in his liver, in his spleen and in his gut in general. So, he fits the description of vaccine-induced pro-thrombotic thrombocytopenia. He fits the case description," Dr Norman Swan, the host of the Coronacast podcast, told the broadcaster.
The Therapeutic Goods Administration is investigating the case. It is so far unclear whether the thrombosis is linked to the inoculation.
In mid-March, several EU countries halted the rollout of the AstraZeneca vaccine following dozens of reports of blood clotting after inoculations.
However, the European Medicines Agency has found no direct link between the vaccine and thrombosis, recommending that the inoculations continue.
- Canada registers first case of clase I mpox
- USA: First case of bird flu infection reported in child in California
- Over 260 million people in USA will be either obese or overweight by 2050, reveals new study
- New report shows unhealthy eating drives $8 trillion in annual hidden costs
- WHO lists 17 pathogens as top priorities for developing new vaccine
